These findings indicate that while GALE may not be significantly altered in the disease state itself, methotrexate’s therapeutic mechanism in atopic dermatitis may involve a substantial enhancement of GALE enzymatic activity, potentially restoring normal galactose metabolism and improving skin barrier function through metabolic rebalancing rather than correcting an existing deficiency. Here, GALE is linked to atopic eczema.